Viewing StudyNCT06049082

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 7:31 PM
Last Modification Date: 2024-10-26 @ 3:09 PM
Study NCT ID: NCT06049082
Status: RECRUITING
Last Update Posted: 2024-05-06
First Post: 2023-09-15
Brief Title: A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
Sponsor: Krystal Biotech Inc
Organization: Krystal Biotech Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Alpha 1-Antitrypsin Deficiency
Keywords: